SCHEMBL7013786

SCHEMBL7013786

CN1CCC(N2CCN(C(=O)[C@H](N)Cc3cc(Br)c(O)c(Br)c3)CC2)CC1

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CALCRL Q16602 2/20 0.42
CYP3A4 P08684 1/20 0.42
L3MBTL3 Q96JM7 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
SMYD3 Q9H7B4 3/20 0.42
CHRM1 P11229 2/20 0.39
OPRK1 P41145 3/20 0.39
DPP8 Q6V1X1 1/20 0.38
CALCA P06881 1/20 0.37
F10 P00742 1/20 0.37
OPRD1 P41143 2/20 0.37
HDAC8 Q9BY41 1/20 0.37
RAMP1 O60894 1/20 0.37
HRH2 P25021 1/20 0.37
HRH1 P35367 1/20 0.37
GAA P10253 1/20 0.36
TSHR P16473 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7014034 0.97 CALCRL (0.43) CALCRLCYP3A4L3MBTL3L3MBTL1SMYD3
SCHEMBL7006555 0.92 L3MBTL3 (0.41) CALCRLCYP3A4L3MBTL3L3MBTL1SMYD3
SCHEMBL4717937 0.87 L3MBTL3 (0.38) CALCRLCYP3A4L3MBTL3L3MBTL1SMYD3
SCHEMBL3959186 0.87 CYP3A4 (0.53) CALCRLCYP3A4L3MBTL3L3MBTL1SMYD3
SCHEMBL4717842 0.85 L3MBTL3 (0.41) CALCRLCYP3A4L3MBTL3L3MBTL1SMYD3
SCHEMBL30111796 0.84 HDAC8 (0.55) L3MBTL3L3MBTL1SMYD3CHRM1OPRD1
SCHEMBL5661447 0.83 CYP3A4 (0.48) CALCRLCYP3A4CALCA
SCHEMBL3311183 0.83 OPRK1 (0.39) CALCRLCYP3A4L3MBTL3L3MBTL1SMYD3
Trifluoroacetic Acid SCHEMBL7012285 0.81 DPP4 (0.47) CALCRLSMYD3CHRM1OPRK1OPRD1
Trifluoroacetic Acid SCHEMBL7011220 0.81 DPP4 (0.48) CALCRLCYP3A4L3MBTL3L3MBTL1SMYD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1163239-B1 MODIFIED AMINO-ACID AMIDES AS CGRP ANTAGONISTS BOEHRINGER INGELHEIM PHARMA (DE) 2003-05-28 EP disclosed
US-6313097-B1 TREATMENT OR PROPHYLAXIS OF MIGRAINE OR CLUSTER HEADACHES, NON-INSULIN-DEPENDENT DIABETES MELLITUS, INFLAMMATION, ALLERGIC RHINITIS, ASTHMA, MORPHINE TOLERANCE, MENOPAUSAL HOT FLASHES, DISEASES CHARACTERIZED BY EXCESSIVE VASODILATATION BOEHRINGER INGELHEIM PHARMA KG (DE) 2001-11-06 US disclosed